Test Price
2,800 AED✅ Home Collection Available
CEP41 Gene Joubert Syndrome Type 15 Genetic Test in UAE • 2,800 AED • 2026 DHA Guidelines
تحليل جين CEP41 لمتلازمة جوبيرت النوع 15 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – Your Genomic Certainty Roadmap
- ✔ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑accredited NGS processing, targeting the entire CEP41 coding region with deep sequencing (>100x mean coverage).
- ✔ Premium Logistics: Paid hospital‑grade home collection by DHA‑licensed phlebotomists. Cold‑chain transport of DNA‑stabilised samples (FTA card or whole blood) in compliance with ISO 9001:2015.
- ✔ Clinical Guidance: Telephonic post‑test clinical correlation session with a DHA‑certified clinical geneticist or neurologist, available in English and Arabic.
- ✔ Insurance: Direct billing verification via WhatsApp to +971 54 548 8731. Pre‑approval letter within 2 hours.
ملخص تنفيذي: فحص جيني طبي متقدم لتحديد الطفرات في جين CEP41، المسبب لمتلازمة جوبيرت من النوع الخامس عشر. يُجرى التحليل وفق أحدث تقنيات تسلسل الجيل التالي (NGS) وبدقة تشخيصية فائقة تصل إلى 99.9%، مع التزام صارم بقانون المسؤولية الطبية الاتحادي رقم 41 لعام 2024 ومعايير هيئة الصحة بدبي. تشمل الخدمة جلسة استشارة وراثية مجانية بعد النتيجة، وسحب عينة منزلية آمن وفق أعلى مواصفات الأيزو.
Test Overview – What Is the CEP41 Gene Joubert Syndrome Type 15 DNA Test?
This clinical-grade next‑generation sequencing (NGS) test comprehensively screens the CEP41 gene for pathogenic variants linked to Joubert syndrome type 15, a rare ciliopathy characterised by cerebellar vermis hypoplasia, hypotonia, and oculomotor apraxia. Designed for symptomatic patients, at-risk families, and researchers, the assay delivers a definitive molecular diagnosis, guiding early intervention and personalised neurological care under DHA oversight.
يُعطي التحليل تشخيصًا جزيئيًا دقيقًا لمتلازمة جوبيرت النوع 15 عبر فحص كامل الشيفرة الجينية لجين CEP41.
Our Test vs. Closest Alternative
| Feature | Our CEP41 NGS Test | Standard Single‑Gene Sequencing |
|---|---|---|
| Methodology | NGS (Illumina® HiSeq), full coding exons ±20 bp splice sites | Sanger sequencing (limited to selected exons only) |
| Analytical Sensitivity | >99.9% for single nucleotide variants & small indels | ~95% (may miss deep intronic or large rearrangements) |
| Turnaround Time | 3–4 weeks with expedited clinical report | 5–7 weeks |
| Regulatory Compliance | DHA‑licensed facility (License #9834453); ISO 9001:2015 | Varies; often lacks UAE‑specific accreditation |
Physician Insight & Safety Protocol
“As a senior neurologist, I emphasise that a positive CEP41 variant confirms the clinical diagnosis of Joubert syndrome type 15, but every genetic result must be interpreted in light of the patient’s full clinical picture and family history. Never initiate or alter treatment based solely on a genetic test; always discuss the findings with a multidisciplinary team. Your family’s peace of mind begins with expert post‑test counselling.”
— Dr. PRABHAKAR REDDY, DHA Licence No. 61713011
⛔ Medication Warning
Do not discontinue or modify any prescribed medication without consulting your treating physician. This genetic test provides diagnostic information, not therapeutic guidance. Abrupt changes to antiepileptic or neurological drugs may provoke serious adverse events.
⚠️ Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients unable to provide informed consent (and lacking a legally authorised representative) as per CDS Law 2026 for minors.
- Red Flag: Sudden worsening of hypotonia, apnoeic episodes, or seizure clusters in an infant awaiting results – proceed immediately to the nearest emergency department.
- Red Flag: If the DNA sample is compromised (e.g., clotted blood tube), recollection will be offered at no extra charge.
Frequently Asked Questions (FAQ)
What is the clinical purpose of the CEP41 gene test, and how accurate is it?
This definitively identifies pathogenic mutations in the CEP41 gene causing Joubert syndrome type 15 with >99.9% diagnostic sensitivity, confirming clinical suspicion in patients and identifying carrier status in at‑risk relatives.
هل يتطلب التحليل صيامًا أو تحضيرات خاصة قبل سحب العينة؟
لا يحتاج تحليل جين CEP41 إلى صيام أو تجهيزات دوائية مسبقة؛ تكتفي المختبر بعينة دم بسيطة أو مسحة حمض نووي على بطاقة FTA، مع استشارة وراثية مسبقة لرسم شجرة العائلة بدقة.
How will I receive my results and what support is provided afterwards?
Your comprehensive report is delivered within 3–4 weeks via a secure DHA‑compliant portal, followed by a complimentary tele‑consultation with a clinical geneticist who will explain variant interpretation, recurrence risk, and next steps for family planning.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians